NEW YORK (GenomeWeb) – Isoma Diagnostics, a spinout of Philadelphia's Wistar Institute, has secured a first round of seed funding from Ben Franklin Technology Partners and the University City Science Center's Phase I Ventures Program.

The company did not disclose the funding amount, but a Wistar Institute spokesperson noted that it was in the six-figure range.